Clinical Trial Update: Pramipexole for Anhedonic Depression [Phase 3]

View source ↗

Summary

Phase 3 trial update for pramipexole in anhedonic depression has completed enrollment and status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia
• Major Depressive Disorder
• Psychiatric Disorders

Drugs mentioned

• Pramipexole (pramipexole)

Snippet

Sponsor: Region Skane | Conditions: Psychiatric Disorders Mood, Anhedonia | Phase 3 | Status: COMPLETED